Home > Insider Trading > Filing (0001209191-16-113453)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Laboratory Analytical Instruments (3826)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187574	Stuart Essig	311 C Enterprise Drive Plainsboro NJ 08536		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-04-04	42,150	$36.80	1,002,469	No	4	M	Direct
Common Stock	Disposition	2016-04-04	42,150	$67.26	960,319	No	4	S	Direct
Common Stock	Acquisiton	2016-04-05	41,140	$36.80	1,001,459	No	4	M	Direct
Common Stock	Disposition	2016-04-05	41,140	$66.08	960,319	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2016-04-04	42,150	$0.00	42,150	$36.80
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2016-04-05	41,140	$0.00	41,140	$36.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
166,630		2016-12-19	No	4	M	Direct
125,490		2016-12-19	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan previously adopted by the reporting person.
Includes 473 shares of common stock issued as restricted stock pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $67.00 to $67.85.
The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $65.83 to $66.70.
25% of the option grant vested on 12/19/2007 (the first anniversary of the grant date of 12/19/2006), and the remaining 75% vested monthly thereafter over 36 months.
This option was previously reported as covering 200,000 shares at an exercise price of $42.53 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.